Elliot Israel is a Respiratory physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 17 publications with 1,529 citations (h-index 7); ClinicalTrials.gov lists 19 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 Cypress St
Brookline, MA 024456002
Telephone
857-307-0896Provider last certified this registry record 2 Jun 2026.
Clinical trials
- Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban
Sponsor: Brigham and Women's Hospital
- Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief
Sponsor: Brigham and Women's Hospital
- Fatty Acids in Airway Smooth Muscle of Asthmatics
Sponsor: Brigham and Women's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20253 payments
- Chiesi USA, Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
15 NIH research awards on record, funded 1993–2023 per NIH RePORTER. The latest:
- Immunometabolic phenotypes in adult severe asthma and disease progression
Brigham and Women'S Hospital
FY2023$3,233,979U01HL146002 - Immunometabolic phenotypes in adult severe asthma and disease progression
Brigham and Women'S Hospital
FY2023$216,239U01HL146002 - Immunometabolic phenotypes in adult severe asthma and disease progression
Brigham and Women'S Hospital
FY2022$3,322,614U01HL146002
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Characterization of factors associated with systemic corticosteroid use in severe asthma: Data from the Severe Asthma Research Program
Journal of Allergy and Clinical Immunology
2013 - The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma
Annals of Internal Medicine
1993
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”